Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ohana
D Plotquin
D Atar

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Public Health|March 23, 2005
The prevalence of obesity and associated morbidity among 17-year-old Israeli conscriptsY Bar Dayan, K Elishkevits, I Grotto, et al.
Heart (British Cardiac Society)|November 18, 2003
Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of CopenhagenI Raymond, F Pedersen, F Steensgaard-Hansen, et al.
Circulation|January 4, 2001
Cardiac troponin I is modified in the myocardium of bypass patientsJ L McDonough, R Labugger, W Pickett, et al.
European Journal of Heart Failure|August 19, 2003
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirinV L Serebruany, A H Glassman, A I Malinin, et al.
European Heart Journal|May 15, 2015
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trialJ Steffel, R P Giugliano, E Braunwald, et al.
Basic Research in Cardiology|September 27, 2000
Lack of nuclear apoptosis in cardiomyocytes and increased endothelin-1 levels in a rat heart model of myocardial stunningM Klainguti, S Aigner, J Kilo, et al.
BMC Medical Ethics|October 1, 2024
Moral distress and protective work environment for healthcare workers during public health emergenciesK Bondjers, Alve K Glad, H Wøien, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Gender differences in the effects of cardiovascular drugsJ Tamargo, G Rosano, T Walther, et al.
European Heart Journal|February 22, 2013
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapyStefan Agewall, M Cattaneo, J P Collet, et al.
European Heart Journal. Acute Cardiovascular Care|May 15, 2020
Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct sizeNoreen Butt, L K Bache-Mathiesen, A Ushakova, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Public Health|March 23, 2005
The prevalence of obesity and associated morbidity among 17-year-old Israeli conscriptsY Bar Dayan, K Elishkevits, I Grotto, et al.
Heart (British Cardiac Society)|November 18, 2003
Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of CopenhagenI Raymond, F Pedersen, F Steensgaard-Hansen, et al.
Circulation|January 4, 2001
Cardiac troponin I is modified in the myocardium of bypass patientsJ L McDonough, R Labugger, W Pickett, et al.
European Journal of Heart Failure|August 19, 2003
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirinV L Serebruany, A H Glassman, A I Malinin, et al.
European Heart Journal|May 15, 2015
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trialJ Steffel, R P Giugliano, E Braunwald, et al.
Basic Research in Cardiology|September 27, 2000
Lack of nuclear apoptosis in cardiomyocytes and increased endothelin-1 levels in a rat heart model of myocardial stunningM Klainguti, S Aigner, J Kilo, et al.
BMC Medical Ethics|October 1, 2024
Moral distress and protective work environment for healthcare workers during public health emergenciesK Bondjers, Alve K Glad, H Wøien, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Gender differences in the effects of cardiovascular drugsJ Tamargo, G Rosano, T Walther, et al.
European Heart Journal|February 22, 2013
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapyStefan Agewall, M Cattaneo, J P Collet, et al.
European Heart Journal. Acute Cardiovascular Care|May 15, 2020
Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct sizeNoreen Butt, L K Bache-Mathiesen, A Ushakova, et al.
Pageof 16